164 out of 444 general lectures (37 %) at the Japanese Society for Food Science and Technology Convention in Sapporo are from companies
Nikkei Biotech, August 30, 2012
IBL press release, August 29, 2012 (Japanese)
The modular system allows a dosage of 900 L and has a footprint of 0.6 m2. The machine was tested in cooperation with Professor Mitsuo OKANO‘s group at Tokyo Women’s Medical University who is tackling regenerated tissues such as a cornea, cardiac muscle, esophagus, and cartilago. Hitachi news release, August 29, 2012
The CARTA framework enables classification of subcellular localization, mitotic phases and discrimination of apoptosis in images of plant and human cells with an accuracy level greater than or equal to annotators Natsumaro Kutsuna et al., Nature Communications, 28 August 2012
This type of equipment is used for the treatment of infiltrating carcinoma. Development is in collaboration with the University of Tsukuba and the Japan Atomic Energy Agency. Nikkei Biotech August 27, 2012
Research team comprises NAIST and Tokyo Institute of Technology’s Prof. Hatano YAMAZAKI. JST press release, August 23, 2012
Results are released as a joined paper with Tokyo Women’s Medical University. Cell Seed press release, JASDAQ, August 21, 2012
Lenvatinib is a multi-kinase inhibitor invented by Eisai. Eisai press release, August 20, 2012
The plant, named “ice crystal” in Swaheli, has been baptized “Barafu” in Japanese and is developed into various health food (mineral balance) and cosmetics applications, e. g., into a moisturing and anti-wrinkle cosmetic. https://www.barafu.jp/index.html
The products are under the brand of “Health Manage” and comprise a barley verdure green soup containing dextrin which is difficult to digest and controls blood sugar levels, and an “angelica green soup chitosan” which controls the level of cholesterol in blood. Both agents were granted FOSHU states by the consumer agency on March 12. […]